7.41
-0.55 (-6.91%)
-0.55 (-6.91%)
Upgrade to Real-Time
Regular Market
| Volume | 2,924,405 |
|
|||||
| News | (2) | ||||||
| Day High | 8.00 | Low High |
|||||
| Day Low | 7.36 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.55 | -6.91% | 7.41 | 11:35:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.81 | 7.36 | 8.00 | 7.96 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,592 | 2,924,405 | $ 7.65 | $ 22,383,704 | - | 4.862 - 24.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:36:29 | 500 | $ 7.41 | USD |
Period:
Draw Mode:
Vaxart Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 929.93M | 125.50M | 124.78M | $ 4.05M | $ - | -0.35 | -14.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 49.10k | 2.30% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.70 | 8.13 | 6.56 | 7.58 | 5,766,560 | 0.71 | 10.6% |
| 1 Month | 7.18 | 8.13 | 6.41 | 7.09 | 3,675,289 | 0.23 | 3.2% |
| 3 Months | 8.6055 | 9.40 | 6.41 | 7.35 | 3,547,696 | -1.20 | -13.89% |
| 6 Months | 6.62 | 10.33 | 6.41 | 8.01 | 6,854,314 | 0.79 | 11.93% |
| 1 Year | 8.46 | 24.90 | 4.862 | 8.72 | 11,182,204 | -1.05 | -12.41% |
| 3 Years | 3.24 | 24.90 | 0.2543 | 7.48 | 9,061,821 | 4.17 | 128.7% |
| 5 Years | 15.2889 | 24.90 | 0.2543 | 7.46 | 5,622,629 | -7.88 | -51.53% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
